Whole eye external beam radiotherapy for retinoblastoma is associated with severe ocular morbidity which often leads to substantial loss of vision and produces painful, photophobic, and unsightly eyes which are difficult to treat.1-5 Although radiation chorioretinopathy and optic neuropathy have been minimised by reducing the total dose of radiation delivered to the eye and by increasing the fractionation,3 4 610 the harmful effects of radiation on the ocular adnexa and on the anterior segment of the eye have proved more difficult to eliminate.
Several methods have been devised for sparing the lids and anterior segment while delivering a homogeneous dose of radiation to Tables 1  and 2 .
To make the series as compatible as possible with the whole eye study, eyes were included only when lens sparing radiotherapy had been the primary form of treatment of their disease. In order to take advantage of the benefits of sparing the lens and anterior segment, some eyes were selected for the lens sparing technique despite having additional small tumours located anterior to the equator and therefore outside the collimated beam. These eyes were first treated focally, usually by triple freeze cryotherapy though occasionally by a radioactive scleral plaque. Eyes which received focal pretreatment of anterior tumours were not excluded from the present study. However, those eyes which received lens sparing radiotherapy because of failure of prior focal treatment were not included in the present analysis. Additional criteria for inclusion were: the availability of complete follow up data and a minimum follow up period of 12 months.
Each case underwent examination under anaesthesia. Indirect ophthalmoscopy with scleral indentation, retinal drawings, fundus photography, diagnostic computed tomography (CT) scanning and B scan ultrasonography were performed. Each affected eye was then graded according to the Reese-Ellsworth classification.14 A scan ultrasonography was utilised to determine the distance from the anterior corneal surface to the posterior surface of the lens. The technique has been described in full elsehwere. 5 In brief, a standard 6 MV linear accelerator beam has been modified to produce a non-divergent and almost penumbra free anterior beam edge by a beam splitting and extetaded collimation system (Fig 1) . Using a contact lens to provide a reference point on the surface of the eye and an attached rod and scale measuring system directly linked to the collimator it has been shown that, based on the A scan measurements, the anterior border of the radiation field can be placed behind the lens of the eye with 0 5 mm accuracy in a supine, immobilised, and anaesthetised infant. If the contralateral eye has been enucleated, a direct lateral field is used. When both eyes require lens sparing external beam radiotherapy, horizontally opposed lateral fields are employed (Fig 2) . If the contralateral eye is healthy, the radiation portal is angled 400 in a superoinferior direction, exiting through the contralateral maxilla (Fig 3) . Throughout the period of the study the dose employed was 40 Gy administered in 20 fractions over 28 days. 5 The results of treatment were first assessed 1 month after completion of radiotherapy and thereafter at 3 monthly intervals for the first post-treatment year followed by longer intervals according to the response. Patients who had focal treatment of pre-equatorial tumours were re-examined approximately half way through radiotherapy to ensure that their anterior tumours were controlled. Additional focal treatment was given to these children when necessary. Eyes which developed recurrences and new tumours after lens sparing external beam radiotherapy could often be salvaged by focal therapy. Cryotherapy was the method of choice for single or multiple tumours 6 mm or less in diameter and radioactive scleral plaque therapy with an iodine-125 or ruthenium-106/rhodium-106 applicator for single lesions more than 6 mm and up to 13 mm in diameter.
In Figure 4 summarises the initial results of lens sparing external beam radiotherapy. Treatment was successful in 48 eyes (72%). Treatment failure (failure to control tumour growth or local recurrence) occurred in six eyes (9%). New tumours developed in 13 eyes (19%). Ninety three per cent of the new tumours arose anterior to the equator. Time to diagnosis of treatment failure or new tumour development ranged from 2 to 25 months (mean 10 months). Table 3 lists the initial success rate following lens sparing radiotherapy, the salvage rate among those eyes requiring further treatment and the overall success rate by Reese-Ellsworth group. Three of the treatment failure eyes required enucleation. Salvage therapy (cryotherapy/plaque therapy) was attempted for the other three failed eyes and for all 13 eyes with new tumours. This was successful in 14/16 eyes (88%).
Overall five eyes (7°/O) required enucleation, all for failure to control tumour growth. Two eyes were enucleated for persistent tumour growth anterior to the equator, two for tumours posterior to the equator, and one for In order to avoid these complications, various forms of radiotherapy aimed at sparing the lens/anterior segment have been developed. To achieve accurate and reproducible irradiation of an eye with the aim of treating the entire retina, while at the same time protecting the lens/anterior segment, makes considerable demands on the technique employed. This is attributable to the close anatomical proximity of the structures involved, in addition to the radiosensitivity of the lens.
The minimum total cataractogenic dose following radiotherapy in single or fractionated applications has been reported to be as low as 200 cGy and as high as 1000 cGy.12 18 19 Although the total dose of radiation for the treatment of retinoblastoma has been reduced over the years, a dose of 3500-5000 cGy fractionated over 3-6 weeks is recommended by most centres.
Several Figure 4 Initial results oflens sparing extemal beam radiotherapy. ularly in children treated before the age of 1 year. When only one eye was treated this led to facial asymmetry in some instances, however, this has generally been less marked than that observed after whole eye treatment, presumably because the treated volume of bone is significantly less when the lens and anterior segment are spared. The opportunity to avoid dry, vascularised, painful, and photophobic eyes in carefully selected children has substantially improved comfort and cosmesis compared with similar patients treated by whole eye external beam radiotherapy.
To capitalise fully on the advantages of sparing the lens and anterior segment, the eye preservation rate should be at least as good as that achieved employing a whole eye approach. In a study comparing the results of whole eye and lens sparing radiotherapy, Foote and coworkers noted a higher tumour control rate following primary whole eye radiotherapy in comparison with lens sparing radiotherapy (64% cf 29%). They concluded that whole eye irradiation was the preferable mode of treatment. However, when their data on ocular survival are analysed, there appears to be a comparable success rate between the two methods (whole eye 82% cf lens sparing 79%).22 Table 4 compares the overall success rates of lens sparing and whole eye external beam radiotherapy including salvage focal treatment in our series. Most of the lens sparing patients were in Reese-Ellsworth groups I to III though a few group IV patients fulfilled the selection criteria. Because sparing the lens was considered inappropriate for some group IV patients it is only possible to make direct comparisons with the whole eye approach in groups I to III. External beam radiotherapy was universally successful following both methods for group I tumours which were small lesions irradiated externally because of their location close to the optic disc or macula (p=1). An improvement in overall success rate following lens sparing compared with whole eye treatment was observed in groups II (p=076) and III (p=0 68) although the difference is not statistically significant.
When the results of treatment for groups I-III are considered collectively, a success rate of 85% was achieved following whole eye and 92% after lens sparing radiotherapy (X2=0-363 group.bmj.com on December 29, 2017 -Published by http://bjo.bmj.com/ Downloaded from Toma, Hungetford, Plowman, Kingston, Doughty In our series, new tumours developed in 13 eyes (19%) and the majority (93%) were located anterior to the equator. The high incidence of new tumours in the unirradiated anterior retina concurs with other studies in which the incidence of new tumours was 6-27%, of which 67-90% developed anterior to the equator.12 [22] [23] [24] Our experience suggests that, when sparing the lens, new anterior tumours arising in the unirradiated field lead to a substantial increase in the overall incidence of new lesions. In an analysis of 175 eyes treated by whole eye radiotherapy, the incidence of new tumours was significantly lower at 5% (X2= 10X8, p=0 001) with only 22% (X2=8-5, p=0 004) of these developing anterior to the equator.13 Several authors have referred to the prophylactic effect of radiotherapy on the development of new tumours.2 6 12 This effect probably results from destruction of tumours which are too small to visualise ophthalmoscopically. The results of various series12 13 The higher incidence of new anterior tumours did not reduce the overall ocular cure rate of lens sparing compared with whole eye radiotherapy (Table 4 ). This is due to careful monitoring post radiotherapy thus allowing early detection and treatment of these tumours by judicial use of focal salvage techniques.
This preliminary study suggests that, unless, with longer follow up, a significant number of unsalvageable late relapses are seen in the lens sparing group, the modified Schipper technique is appropriate for all eyes in ReeseEllsworth groups I to III. Furthermore, the lens may be spared in group IV eyes provided that any tumours anterior to the equator are amenable to focal adjuvant therapy. In the presence of anterior tumours too large for focal therapy or of a retinal detachment extending forwards to the ora serrata we would advocate including the whole retina and therefore the posterior part of the lens in the treatment field. In our view, the potential for anterior chamber extension in vitreous seeding is sufficient to justify applying a whole eye radiation field in eyes with this finding, and for which a conservative approach can be justified. In carefully selected cases, the modified Schipper technique together with adjuvant and salvage focal therapy has so far produced a local ocular cure rate at least as good as whole eye external beam radiotherapy but without the associated anterior segment morbidity.
